Related Experiment Videos

Oncogenic transformation systems involving mammalian cells in vitro to determine the relative risks of different

Strahlentherapie
|December 1, 1984
PubMed

Insights

This study assessed the carcinogenic potential of various chemotherapy drugs and radiosensitizers using mouse fibroblast cells. Some agents, like cis-Platinum, showed high oncogenic transformation, while others, such as hyperthermia, had protective effects.

Area of Science:

  • Oncology
  • Cell Biology
  • Carcinogenesis Research

Background:

  • In vitro oncogenic transformation assays are crucial for screening carcinogens and identifying cancer-inhibiting compounds.
  • Mouse fibroblast (10T1/2) cell line provides a model for evaluating oncogenic potential of physical and chemical agents.

Purpose of the Study:

  • To compare the oncogenic transformation incidence induced by X-rays, heat, hypoxic cell radiosensitizers, and chemotherapy agents.
  • To evaluate the potential carcinogenicity of nitroimidazole radiosensitizers and common chemotherapy drugs.
  • To investigate the effect of hyperthermia and superoxide dismutase (SOD) on radiation-induced transformation.

Main Methods:

  • Utilized 10T1/2 mouse fibroblast cell line cultured in vitro.
  • Exposed cells to X-rays, hyperthermia (40°C), various nitroimidazole radiosensitizers (metronidazole, misonidazole, SR-2508, etc.), and chemotherapy agents (Vincristine, cis-Platinum).
  • Assayed oncogenic transformation incidence and cell killing rates; assessed the impact of SOD and hyperthermia on transformation.

Main Results:

  • Most nitroimidazole radiosensitizers induced transformation comparable to 1 Gy X-rays, except SR-2508, which was five-fold higher.
  • Chemotherapy agents showed varied oncogenic potential; Vincristine showed no detectable transformation, while cis-Platinum was a potent carcinogen.
  • Hyperthermia alone did not cause transformation and reduced X-ray-induced transformation; SOD reduced transformation when present during fixation and expression phases.

Conclusions:

  • The carcinogenic potential of radiosensitizers like SR-2508 warrants careful consideration for clinical trials.
  • Chemotherapy agents exhibit a wide range of oncogenic risks, with cis-Platinum posing a significant concern.
  • Hyperthermia and SOD demonstrate protective effects against oncogenic transformation, suggesting potential therapeutic applications.

Related Concept Videos